TransMedics TMDX
NASDAQ TMDX
$78.64 -4.81 (-5.76%)
At close: Oct 1, 2026 · 4:00 PM EDT

TransMedics (TMDX) Liabilities and Shareholders Equity (2018 - 2026)

Updated

TransMedics (TMDX) posted Liabilities and Shareholders Equity of $1.46 billion for Q2 2026, up 64.4% from $890.52 million a year earlier and up 2.1% from the prior quarter.

Analysis

TransMedics (TMDX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, TransMedics' Liabilities and Shareholders Equity came in at $1.07 billion, up 32.9% from FY2024.

  • Annual Liabilities and Shareholders Equity has increased for four consecutive years, with a five-year compound annual growth rate of 47.7% (FY2020 to FY2025).
  • In prior years, TransMedics' Liabilities and Shareholders Equity was $804.08 million in FY2024 (+13.9%), $706.05 million in FY2023 (+154.8%), $277.15 million in FY2022 (+105.5%) and $134.89 million in FY2021 (-11.3%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2018.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last 16 quarters, with growth averaging 31.3% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q2 2023, with growth of 488.6%; the weakest was Q3 2021, with a decline of 17.7%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $1.43 billion (Q1 2026), $1.07 billion (Q4 2025) and $946.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 TransMedics 2.89 Bn 1.00 Bn 113.20 Mn 1.46 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.46 Bn
Mar 31, 2026 1.43 Bn
Dec 31, 2025 1.07 Bn
Sep 30, 2025 946.03 Mn
Jun 30, 2025 890.52 Mn
Mar 31, 2025 837.53 Mn
Dec 31, 2024 804.08 Mn
Sep 30, 2024 785.57 Mn
Jun 30, 2024 758.58 Mn
Mar 31, 2024 723.83 Mn
Dec 31, 2023 706.05 Mn
Sep 30, 2023 689.23 Mn
Jun 30, 2023 690.36 Mn
Mar 31, 2023 287.09 Mn
Dec 31, 2022 277.15 Mn
Sep 30, 2022 274.87 Mn
Jun 30, 2022 117.29 Mn
Mar 31, 2022 124.01 Mn
Dec 31, 2021 134.89 Mn
Sep 30, 2021 131.15 Mn
API Access

TransMedics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TMDX&period=max&api_key=YOUR_API_KEY